Genetic advances in neurodevelopmental disorders DOI Creative Commons
Shilin Gao,

Chaoyi Shan,

Rong Zhang

et al.

Medical Review, Journal Year: 2024, Volume and Issue: 5(2), P. 139 - 151

Published: Sept. 2, 2024

Neurodevelopmental disorders (NDDs) are a group of highly heterogeneous diseases that affect children's social, cognitive, and emotional functioning. The etiology is complicated with genetic factors playing an important role. During the past decade, large-scale whole exome sequencing (WES) genome (WGS) have vastly advanced findings NDDs. Various forms variants been reported to contribute NDDs, such as de novo mutations (DNMs), copy number variations (CNVs), rare inherited (RIVs), common variation. By far, over 200 high-risk NDD genes identified, which involved in biological processes including synaptic function, transcriptional epigenetic regulation. In addition, monogenic, oligogenic, polygenetic, omnigenic models proposed explain architecture However, majority patients still do not definitive diagnosis. future, more types risk factors, well noncoding variants, await be their interplay mechanisms key resolving heterogeneity

Language: Английский

Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses DOI Creative Commons

Steven Laurie,

Iris te Paske,

Nienke van Os

et al.

Nature Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 17, 2025

Genetic diagnosis of rare diseases requires accurate identification and interpretation genomic variants. Clinical molecular scientists from 37 expert centers across Europe created the Solve-Rare Diseases Consortium (Solve-RD) resource, encompassing clinical, pedigree rare-disease data (94.5% exomes, 5.5% genomes), performed systematic reanalysis for 6,447 individuals (3,592 male, 2,855 female) with previously undiagnosed 6,004 families. We established a collaborative, two-level review infrastructure that allowed genetic in 506 (8.4%) Of 552 disease-causing variants identified, 464 (84.1%) were single-nucleotide or short insertions/deletions. These either located recently published novel disease genes (n = 67), reclassified ClinVar 187) by consensus decision within Solve-RD 210). Bespoke bioinformatics analyses identified remaining 15.9% causative 88). Ad hoc review, parallel to reanalysis, diagnosed 249 (4.1%) additional families an overall diagnostic yield 12.6%. The collaborative networks set up can serve as blueprint future further scalable international efforts. resource is open global community, allowing phenotype, variant gene queries, well genome-wide discoveries.

Language: Английский

Citations

2

Advancing long-read nanopore genome assembly and accurate variant calling for rare disease detection DOI
Shloka Negi, Sarah L. Stenton, Seth Berger

et al.

The American Journal of Human Genetics, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

2

Severe Osteoporosis in an Adult Subject with RNU4-2 Gene Mutation DOI
Joshua Peñafiel‐Sam, Irene Valenzuela, Pilar Peris

et al.

Calcified Tissue International, Journal Year: 2025, Volume and Issue: 116(1)

Published: Feb. 17, 2025

Language: Английский

Citations

1

AC129507.1 is a ferroptosis-related target identified by a novel mitochondria-related lncRNA signature that is involved in the tumor immune microenvironment in gastric cancer DOI Creative Commons
Shanshan Yu, Jinxiao Liang, Lixiao Liu

et al.

Journal of Translational Medicine, Journal Year: 2025, Volume and Issue: 23(1)

Published: March 6, 2025

Gastric cancer (GC) is one of the most common malignancies. Previous studies have shown that mitochondrial metabolism associated with However, relevant research on mitochondria-related lncRNAs in GC lacking. We integrated corresponding information patients from The Cancer Genome Atlas (TCGA) database. Mitochondria-related were selected based differential expression and a correlation analysis to construct prognostic model. mutation data analyzed distinguish differences tumor burden (TMB). Single-sample gene set enrichment (ssGSEA) was performed evaluate immunological differences. A series cell-based experiments adopted biological behavior GC. total 1571 identified. signature incorporating nine built 293 suitable cases could predict patient prognosis. TMB ssGSEA indicated low-risk group displayed increased immune function. differentially expressed genes enriched metabolic functions. AC129507.1 significantly upregulated cells poor prognosis, its knockdown inhibited proliferation migration cells. Mechanistically, silencing led abnormal glycolipid oxidative stress, thus inducing ferroptosis. Our nine-lncRNA risk powerfully promoted malignant phenotypes play nonnegligible role by promoting formation immunosuppressive microenvironment inhibiting initiation ferroptosis, which needs be further explored.

Language: Английский

Citations

1

A call to action to scale up research and clinical genomic data sharing DOI
Zornitza Stark, David Glazer, Oliver Hofmann

et al.

Nature Reviews Genetics, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 7, 2024

Language: Английский

Citations

6

De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa DOI Creative Commons
Mathieu Quinodoz, Kim Rodenburg, Zuzana Cvačková

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 6, 2025

The U4 small nuclear RNA (snRNA) forms a duplex with the U6 snRNA and, together U5 and ∼30 proteins, is part of U4/U6.U5 tri-snRNP complex, located at core major spliceosome. Recently, recurrent de novo variants in RNA, transcribed from RNU4-2 gene, least two other RNU genes were discovered to cause neurodevelopmental disorder. We detected inherited heterozygous (n.18_19insA n.56T>C) four out five RNU6 paralogues (n.55_56insG n.56_57insG) 135 individuals 62 families non-syndromic retinitis pigmentosa (RP), rare form hereditary blindness. show that these are among RP invariably cluster close proximity within three-way junction (between stem-I, 5' stem-loop stem-II) U4/U6 duplex, affecting its natural conformation. Interestingly, this region binds numerous splicing factors complex including PRPF3, PRPF8 PRPF31, previously associated as well. identified seem affect snRNP biogenesis, namely di-snRNP, which an assembly intermediate tri-snRNP. Based on number positive cases observed, deleterious could be significant isolated or dominant RP, accounting for up 1.2% all undiagnosed cases. This study highlights role non-coding Mendelian disorders uncovers pleiotropy , where different underlie disorder RP.

Language: Английский

Citations

0

RNA splicing: a split consensus reveals two major 5′ splice site classes DOI Creative Commons
Matthew T Parker, Sebastian M. Fica, Gordon G. Simpson

et al.

Open Biology, Journal Year: 2025, Volume and Issue: 15(1)

Published: Jan. 1, 2025

The established consensus sequence for human 5′ splice sites masks the presence of two major site classes defined by preferential base-pairing potentials with either U5 snRNA loop 1 or U6 ACAGA box. are separable in genome sequences, sensitized specific genotypes and associated splicing complexity. reflect commitment to usage occurring primarily during transfer snRNA. Separating into its constituents can help us understand fundamental features eukaryote architecture mechanisms inform treatment design diseases caused genetic variation affecting splicing.

Language: Английский

Citations

0

Reanalysis of whole genome sequencing ends a diagnostic Odyssey of neurodevelopmental disorders caused by RNU4-2 variants DOI
Shiqi Fan,

Shuanghao Yang,

Miao Sun

et al.

Science China Life Sciences, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 17, 2025

Language: Английский

Citations

0

Expanding the mutational spectrum of ReNU syndrome: insights into 5’ Stem-loop variants DOI
Alessandro Bruselles, Cecilia Mancini,

Luigi Chiriatti

et al.

European Journal of Human Genetics, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 26, 2025

Language: Английский

Citations

0

Are vagal neural crest derived tissues impacted in spliceosomopathies? DOI
Joshua Moore, Loydie A. Jerome‐Majewska

Differentiation, Journal Year: 2025, Volume and Issue: unknown, P. 100846 - 100846

Published: Feb. 1, 2025

Language: Английский

Citations

0